Jakarta - PT Industri Jamu and Pharmacy Sido Muncul Tbk (SIDO) until the end of the first semester of 2021 spent capital expenditure (capex) of 30%.

Finance Director of Sido Muncul's Herbal and Pharmaceutical Industry Leonard said the company had prepared a capital expenditure of Rp 200 billion this year.

"The realization until the first half of this year is 30% of the total capex. We allocate capital expenditures to accommodate product innovation and procurement of capsule and softgel machines," he said at the Public Expose (PubEx) Live 2021 in Jakarta on Thursday (9/9).

According to Leonard, until the first semester of 2021, the company earned Rp1.65 trillion in sales.

"The realization of this sale grew by 13.36% compared to the same period last year of Rp1.45 trillion. From this achievement, the company posted a profit for the current period attributable to owners of the parent entity, up 21.31% to Rp502 billion from the